Multimin 90 is a drug owned by WARBURTON TECHNOLOGY LTD. It is protected by 4 US drug patents filed in 2029. All patents are active. Details of Multimin 90’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US10350241 | 30 Nov, 2029 | Active |
| US11000544 | 30 Nov, 2029 | Active |
Exclusivity Information
Multimin 90 holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2029. Details of Multimin 90's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Apr 26, 2029 |
About Multimin 90
Multimin 90 is a drug
owned by WARBURTON TECHNOLOGY LTD.
Multimin 90 uses
Copper Carbonate, Manganese Carbonate, Sodium Selenite, Zinc Oxide as the active
ingredients.
Active Ingredient:
Multimin 90 uses
Copper Carbonate,
Manganese Carbonate, Sodium Selenite, Zinc Oxide
as the active ingredients.
Check out other Drugs and Companies using
Copper Carbonate, Manganese Carbonate, Sodium Selenite, Zinc Oxide ingredient.